Latest News Archive

Please select Category, Year, and then Month to display items

An update on learning and teaching at the UFS

24 March 2020

Dear Student,

We know that many of you might be feeling anxious and uncertain about how the University of the Free State (UFS) is going to take learning and teaching forward during these extraordinary times. On Monday, 16 March 2020, the Rector and Vice-Chancellor, Prof Francis Petersen tasked the Teaching and Learning Management Group (TLMG) to develop alternative ways of taking learning and teaching forward. The TLMG, under the leadership of the Centre for Teaching and Learning (CTL), has been hard at work at developing a new approach.

Like most other universities, our best alternative to continue our learning and teaching is to move online. We are aware that moving online poses many challenges for our students since many of you do not have frequent and reliable access to the internet, or data when you are off-campus, or do not own the necessary devices to learn optimally. We are also aware that learning in a new way will mean that students and staff will need to create spaces for themselves to learn and work at home/off-campus. It does appear that we will be working online for an extended period of time, and we want to assure you that we will be here to support you in this journey as best we can.

The Keep calm, Teach On, and #UFSLearnOn campaigns are aimed at creating the best possible support for lecturers and students, respectively,
by adapting existing support and practices most suited to our new online environment. The new approach has the following components:

Providing and developing support for lecturers to move learning and teaching online.
Creating appropriate communication and support measures to help you learn as effectively as possible. The first of these is the Keep calm and #UFSLearnOn transition resource which will be shared with you through various platforms.
Repositioning existing support systems to create a learning and teaching environment that considers the diverse needs and circumstances of our students.

As a start, here are the Keep calm and #UFSLearnOn dates on which resources will be released:

25 March: This first edition will focus on helping you assess your current realities, and kick-start the planning for learning to continue.
1 April: Release of Edition 2; this edition will be focused on getting connected and understanding how you will be learning when academic activities resume.
8 April: Edition 3 to be released; the third edition will focus on the skills you need to be a successful student in the new environment.
15 April: Edition 4 to be released; this edition will focus on helping you to stay and finish strong. This edition will also provide you with the university’s reassessment of the situation, which will be determined by the country's presidential lockdown situation.

17 April: Academic activities will resume

We are very aware that for many of you access to devices, data, and networks is a challenge. As part of Universities South Africa (USAf), the UFS is negotiating to get our digital learning website zero-rated to minimise your costs. You will be receiving a survey link to provide us with information on the additional support you might need to connect and learn.

We know our students are resourceful and resilient to succeed in extraordinary circumstances. In the meantime, take some time to rest and recharge.

Best wishes,

Dr EL van Staden
Vice-Rector: Academic
University of the Free State

News Archive

Nuclear Medicine on the forefront of cancer research

2017-07-10

Dr Je’nine Horn-Lodewyk’s tumour detection method
could be the cost-effective breakthrough needed to decrease
the mortality rate in breast cancer patients.
Photo: Anja Aucamp

The field of Nuclear Medicine in South Africa and the rest of the world are expanding rapidly due to the development of hybrid cameras and new radiopharmaceuticals. These developments have a huge impact on the diagnosis and therapy of cancer.

The most advanced of these cameras, Positron emission tomography combined with normal CTs (PETCT), are not yet widely available in South Africa due to the cost of the cameras and the radiopharmaceuticals. A more cost-effective alternative can be of great benefit. To achieve this, the focus should be on developing new radiopharmaceuticals that can be used with the current cost-effective gamma cameras, according to University of the Free State researcher, Dr Je’nine Horn-Lodewyk from the Department of Nuclear Medicine.

Fluorodeoxyglucose (18F-FDG), a radiolabelled glucose analogue, is currently the radiopharmaceutical most commonly used in PET/CT imaging for mainly oncology indications. Although it is considered the gold standard for imaging in several malignancies, it does have certain disadvantages. An 18F-FDG PET/CT diagnostic imaging study can cost between R25 000 and R35 000 for a single patient in the private sector. The 18F-FDG is also more radioactive, which requires much stricter handling and shielding to avoid high radiation dosages to staff and patients.

Successful research potential innovative solution
In the search for the ideal radiopharmaceutical for tumour detection, the South African National Nuclear Energy Corporation (Necsa) developed a local synthesis process for ethylenedicysteine-deoxyglucose (EC-DG). EC-DG is also a glucose analogue similar to FDG. They succeeded in labelling the compound with Technetium-99-metastable-pertechnetate (99mTcO4-), the most common nuclear medicine isotope used for approximately 95% of nuclear medicine procedures, creating 99mTc-EC-DG.

In partnership with Dr Horn-Lodewyk, this compound was successfully used in various animal models and clinical scenarios, resulting in approval by the Medicine Control Council to use it in a human study. Research is also planned in order to investigate diagnostic accuracy in other cancers like lymphoma. The end result of this research can produce a radiopharmaceutical that is cost effective, does not require the use of costly specialised equipment, has no significant side-effects, no special patient preparation, renders late imaging possible, and has decreased radiation risks.

Dr Horn-Lodewyk is grateful for the support of her mentor, Prof Anton Otto, as well as Dr Gert Engelbrecht, Head of the Department of Nuclear Medicine, Prof Jan Rijn Zeevaart from North-West University’s Preclinical Drug Development Platform and Necsa, and Judith Wagener from Necsa. This innovative research would also not have been possible without the financial assistance of Dr Glen Taylor and Eleanor van der Westhuizen in the Directorate of Research Development.

Back

Economic and Management Sciences

Education

Health Sciences

The Humanities

Law

Natural and Agricultural Sciences

Theology and Religion

Open Distance Learning

Business School

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept